Epstein-Barr virus-infected antigen-presenting B cell

The term "Epstein-Barr virus antigen-presenting B cell" does not refer to a single defined molecular target, receptor, enzyme, transporter, or protein. Instead, it describes a population of human B lymphocytes that have been infected by the Epstein–Barr virus (EBV) and retain their ability to present antigens via MHC class II molecules. These cells play key roles in both normal immune responses and in the pathogenesis of several diseases. Upon infection by EBV—primarily through binding of viral glycoprotein gp350/220 to CD21 on the surface—B cells undergo activation and can enter various latency programs characterized by distinct patterns of viral gene expression. In these states: - The infected B cells can act as professional antigen-presenting cells (APCs), presenting both self-antigens and viral antigens via MHC class II molecules. - The interaction between the host’s immune system and these APCs is central both for controlling primary infection and for establishing lifelong latency. EBV-infected antigen-presenting B cells are implicated in several disease processes—including infectious mononucleosis during acute infection; persistent latent infections; autoimmune phenomena due to altered immune regulation; and multiple types of cancer when transformation occurs. However, this is not a canonical druggable target like an individual receptor or enzyme. Rather it is an immunological concept describing a functional state of host immune cells during/after viral infection. If you require structured information about actual molecular targets involved in this process—for example CD21/CR2 (the main entry receptor), MHC class II molecules on these APCs, or specific EBV proteins such as LMP1/LMP2A—please specify which molecule you wish detailed data about. In summary: “Epstein–Barr virus antigen-presenting B cell” refers broadly to an infected host immune cell type, not a discrete therapeutic target molecule.

Other names

EBV-infected B cellEpstein-Barr virus-transformed B lymphocyteEBV+ B cellLymphoblastoid cell (when immortalized in vitro)